Scientists have reported reactions to the Russian vaccine from COVID-19

Director, Center for clinical study of drugs sechenovskiy University Elena Smolyarchuk told about how organisms first volunteers respond to the vaccine COVID-19.

The response can be described as the standard characteristic of other injections, said the University.

Smolyarchuk announced that for the first time the vaccine was introduced in the University 18 volunteers. In the first some hours there was a slight increase in temperature, they complained of a headache. During the day these symptoms were independently cropped.

The researcher said that now all the participants of the study feel good. “The effectiveness of the vaccine will judge the developer of the drug, which after the study will conduct laboratory immunological analyses and give a full response,” — said Smolyarchuk. Volunteers all the time, and studies are in terms of protection from external infection coronavirus infection, and to normal life can return in 28 days after vaccination.

In Sechenovskiy University announced Tuesday that an injection of the drug got a further 20 volunteers who are in the Scientific-practical center of interventional Cardioangiology.

Studied at University of vaccine — powder, from which is prepared a solution for intramuscular introduction.

Formerly Director, National research centre of epidemiology and Microbiology named after N. F. Gamalei (NICAM) Alexander Ginzburg said that the transition to mass vaccination of the population it is necessary to produce 50-70 million doses. He suggested that to instill in the population can start already this autumn.

Gunzburg noted that the rapid release of the drug, developed NICAM together with the defense Ministry of Russia for clinical trials due to the use of the technology platform, which is well established in the development of a vaccine against the Ebola virus.